Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions.

[1]  K. Takeda,et al.  Bone morphogenetic protein-2 induces hypophosphorylation of Rb protein and repression of E2F in androgen-treated LNCaP human prostate cancer cells. , 2005, International journal of molecular medicine.

[2]  A. Bosserhoff,et al.  Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration. , 2005, Cancer research.

[3]  A. Waage,et al.  Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cells , 2004, Oncogene.

[4]  Y. Yuasa,et al.  BMP-2 modulates the proliferation and differentiation of normal and cancerous gastric cells. , 2004, Biochemical and biophysical research communications.

[5]  N. Kanomata,et al.  Intraosseous growth of human prostate cancer in implanted adult human bone: Relationship of prostate cancer cells to osteoclasts in osteoblastic metastatic lesions , 2004, The Prostate.

[6]  S. Calvano,et al.  The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells. , 2003, Carcinogenesis.

[7]  Jingyuan Fu,et al.  Signal Transduction of Bone Morphogenetic Proteins in Osteoblast Differentiation , 2003, The Journal of bone and joint surgery. American volume.

[8]  Juan Carlos Izpisúa Belmonte,et al.  Structural Basis of BMP Signaling Inhibition by Noggin, a Novel Twelve-Membered Cystine Knot Protein , 2003, The Journal of bone and joint surgery. American volume.

[9]  J. Clement,et al.  Differential expression and regulation of bone morphogenetic protein 7 in breast cancer. , 2003, International journal of oncology.

[10]  I. Thompson,et al.  Ten-year survival in patients with metastatic prostate cancer. , 2003, Clinical prostate cancer.

[11]  A. Blais,et al.  Overexpression of a dominant negative type II bone morphogenetic protein receptor inhibits the growth of human breast cancer cells. , 2003, Cancer research.

[12]  E. Schwarz,et al.  Differences in the cytokine profiles associated with prostate cancer cell induced osteoblastic and osteolytic lesions in bone , 2003 .

[13]  Markus Affolter,et al.  Structural basis of BMP signalling inhibition by the cystine knot protein Noggin , 2002, Nature.

[14]  Jing Wu,et al.  Use of zoledronate to treat osteoblastic versus osteolytic lesions in a severe-combined-immunodeficient mouse model. , 2002, Cancer research.

[15]  Johnny Huard,et al.  Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. , 2002, The Journal of clinical investigation.

[16]  A. Clark,et al.  Expression of bone morphogenetic proteins (BMP), BMP receptors, and BMP associated proteins in human trabecular meshwork and optic nerve head cells and tissues. , 2002, Molecular vision.

[17]  R. Vessella,et al.  Establishment and characterization of osseous prostate cancer models: Intra‐tibial injection of human prostate cancer cells , 2002, The Prostate.

[18]  Jay R Lieberman,et al.  The role of growth factors in the repair of bone. Biology and clinical applications. , 2002, The Journal of bone and joint surgery. American volume.

[19]  K. Trieb,et al.  The expression of bone morphogenetic proteins in osteosarcoma and its relevance as a prognostic parameter. , 2002, Journal of clinical pathology.

[20]  Anja Nohe,et al.  The Mode of Bone Morphogenetic Protein (BMP) Receptor Oligomerization Determines Different BMP-2 Signaling Pathways* , 2002, The Journal of Biological Chemistry.

[21]  J. Yee,et al.  Development of an MFG-based retroviral vector system for secretion of high levels of functionally active human BMP4. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[22]  E. Schwarz,et al.  Efficacy of Etanercept for Wear Debris‐Induced Osteolysis , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[23]  M. Kumegawa,et al.  Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts. , 2000, Bone.

[24]  R. Jilka,et al.  Essential Requirement of BMPs‐2/4 for Both Osteoblast and Osteoclast Formation in Murine Bone Marrow Cultures from Adult Mice: Antagonism by Noggin , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[25]  L. Gilboa,et al.  Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine/threonine kinase receptors. , 2000, Molecular biology of the cell.

[26]  S. F. Arnold,et al.  Identification of bone morphogenetic proteins and their receptors in human breast cancer cell lines: importance of BMP2. , 1999, Cytokine.

[27]  L. Chung,et al.  Osteomimetic properties of prostate cancer cells: A hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment , 1999, The Prostate.

[28]  H. Friess,et al.  Bone morphogenetic protein 2 exerts diverse effects on cell growth in vitro and is expressed in human pancreatic cancer in vivo. , 1999, Gastroenterology.

[29]  K. Miyazono,et al.  Extracellular matrix-associated bone morphogenetic proteins are essential for differentiation of murine osteoblastic cells in vitro. , 1999, Endocrinology.

[30]  R. Willette,et al.  BMP-2 Gene Expression and Effects on Human Vascular Smooth Muscle Cells , 1999, Journal of Vascular Research.

[31]  J. Schmitt,et al.  Bone morphogenetic proteins: An update on basic biology and clinical relevance , 1999, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[32]  R. Vessella,et al.  Mechanisms, Hypotheses and Questions Regarding Prostate Cancer Micrometastases to Bone , 1998, Cancer and Metastasis Reviews.

[33]  G. Thomas,et al.  BMP‐4 is proteolytically activated by furin and/or PC6 during vertebrate embryonic development , 1998, The EMBO journal.

[34]  A. McMahon,et al.  Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. , 1998, Science.

[35]  A. McMahon,et al.  Noggin-mediated antagonism of BMP signaling is required for growth and patterning of the neural tube and somite. , 1998, Genes & development.

[36]  K. Miyazono,et al.  Signal transduction by bone morphogenetic proteins. , 1998, Cytokine & growth factor reviews.

[37]  Teruhiko Yoshida,et al.  Growth regulation of human prostate cancer cells by bone morphogenetic protein-2. , 1997, Cancer research.

[38]  A. Lassar,et al.  A role for bone morphogenetic proteins in the induction of cardiac myogenesis. , 1997, Genes & development.

[39]  A. Scutt,et al.  Subtle differences in the mitogenic effects of recombinant human bone morphogenetic proteins −2 to −7 on DNA synthesis on primary bone-forming cells and identification of BMP-2/4 receptor , 1996, Calcified Tissue International.

[40]  K. Miyazono,et al.  Cloning and characterization of a human type II receptor for bone morphogenetic proteins. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[41]  J. Massagué,et al.  Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs , 1995, Molecular and cellular biology.

[42]  J. Massagué,et al.  Identification of two bone morphogenetic protein type I receptors in Drosophila and evidence that Brk25D is a decapentaplegic receptor , 1994, Cell.

[43]  D. Riddle,et al.  Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. , 1994, The Journal of biological chemistry.

[44]  J. Wozney,et al.  Expression of bone morphogenetic protein messenger RNAs by normal rat and human prostate and prostate cancer cells , 1994, The Prostate.

[45]  M. Koutsilieris,et al.  Characteristics of prostate-derived growth factors for cells of the osteoblast phenotype. , 1987, The Journal of clinical investigation.

[46]  J. Lechner,et al.  Establishment and characterization of a human prostatic carcinoma cell line (PC-3). , 1979, Investigative urology.

[47]  D. Chan,et al.  Radical prostatectomy as treatment for prostate-specific antigen-detected stage T1c prostate cancer , 2005, World Journal of Urology.

[48]  D. Warburton,et al.  BMP4 signaling induces senescence and modulates the oncogenic phenotype of A549 lung adenocarcinoma cells. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[49]  J. Huard,et al.  Retroviral delivery of Noggin inhibits the formation of heterotopic ossification induced by BMP-4, demineralized bone matrix, and trauma in an animal model. , 2004, The Journal of bone and joint surgery. American volume.

[50]  R L Vessella,et al.  Bone morphogenetic protein signaling in prostate cancer cell lines , 2004, Journal of cellular biochemistry.

[51]  J. Massagué.  TGF-beta signal transduction. , 1998, Annual review of biochemistry.

[52]  Taylor Murray,et al.  Cancer statistics, 1998 , 1998, CA: a cancer journal for clinicians.

[53]  D. Glaves.  Mechanisms of metastasis: prostate cancer. , 1987, Progress in clinical and biological research.